AFG
Albion Financial Group’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Sell |
25,487
-83
| -0.3% | -$33.7K | 0.68% | 43 |
|
|
2025
Q1 | $12.7M | Sell |
25,570
-114
| -0.4% | -$56.7K | 0.9% | 34 |
|
|
2024
Q4 | $13.4M | Sell |
25,684
-378
| -1% | -$197K | 0.91% | 30 |
|
|
2024
Q3 | $16.1M | Buy |
26,062
+67
| +0.3% | +$41.4K | 1.12% | 28 |
|
|
2024
Q2 | $14.4M | Sell |
25,995
-182
| -0.7% | -$101K | 1.08% | 26 |
|
|
2024
Q1 | $15.2M | Sell |
26,177
-130
| -0.5% | -$75.6K | 1.17% | 24 |
|
|
2023
Q4 | $14M | Buy |
26,307
+30
| +0.1% | +$15.9K | 1.15% | 25 |
|
|
2023
Q3 | $13.3M | Buy |
26,277
+364
| +1% | +$184K | 1.23% | 24 |
|
|
2023
Q2 | $13.5M | Sell |
25,913
-1,169
| -4% | -$610K | 1.18% | 26 |
|
|
2023
Q1 | $15.6M | Sell |
27,082
-691
| -2% | -$398K | 1.43% | 19 |
|
|
2022
Q4 | $15.3M | Buy |
27,773
+87
| +0.3% | +$47.9K | 1.48% | 20 |
|
|
2022
Q3 | $14M | Sell |
27,686
-59
| -0.2% | -$29.9K | 1.45% | 18 |
|
|
2022
Q2 | $15.1M | Buy |
27,745
+303
| +1% | +$165K | 1.49% | 16 |
|
|
2022
Q1 | $16.2M | Buy |
27,442
+1,505
| +6% | +$889K | 1.38% | 19 |
|
|
2021
Q4 | $17.3M | Buy |
25,937
+1,643
| +7% | +$1.1M | 1.37% | 22 |
|
|
2021
Q3 | $13.9M | Buy |
24,294
+63
| +0.3% | +$36K | 1.22% | 26 |
|
|
2021
Q2 | $12.2M | Buy |
+24,231
| New | +$12.2M | 1.06% | 29 |
|
|
2020
Q4 | $9.82M | Buy |
21,088
+6,324
| +43% | +$2.95M | 0.96% | 30 |
|
|
2020
Q3 | $6.52M | Buy |
+14,764
| New | +$6.52M | 0.71% | 34 |
|